PRINCETON, N.J., Feb. 9, 2011 /PRNewswire/ — PeriGen, Inc., the
only OB-specific risk reduction company to provide solutions which
generate immediate quantifiable clinical and financial value, today
announced the formation of a strategic alliance with Willis Group
Holdings (NYSE:
WSH), a leading global insurance broker and one of the world’s
largest professional services firms specializing in risk
management. According to the terms of the alliance, Willis will
offer PeriGen’s unique OB-specific products and services to its
clients, in an effort to reduce risk and associated medical
malpractice costs by improving the quality of care delivered.
“As medical malpractice insurance brokers and experts in risk
management, we are very aware of the cost of errors in Obstetrics,”
said Mary S. Botkin, Managing Director, Willis National Health
Care. “Obstetrics ranks first among all specialties for the number
of claims reported and for the total amount of indemnity paid.
PeriGen’s solutions address the root causes behind preventable
medical errors, alerting clinicians to potentially significant
contraindications and identifying safer courses of care. At Willis,
we recognize the unique value of PeriGen’s products and services in
preventing errors and improving clinical outcomes, and we are proud
to offer PeriGen’s solutions to our clients.”
PeriGen’s integrated fetal monitoring, documentation, and
clinical decision support systems help over 15,000 clinicians
provide safer care to their patients. Additionally, PeriGen helps
hospitals to improve clinical and financial outcomes through the
design and implementation of risk management and patient safety
initiatives, clinical quality improvement programs, perinatal
training courses, business improvement programs, and revenue
enhancement strategies. PeriGen’s solutions are complemented by a
full suite of patented, proprietary technolog
‘/>”/>
